EFEITO DO USO PRECOCE DA METFORMINA OU DO ORLISTAT NA PREVENÇÃO DA DISFUNÇÃO DE ADIPÓCITOS EM RATOS WISTAR SUBMETIDOS À DIETA HIPERGLICÍDICA-HIPERLIPÍDICA

EFEITO DO USO PRECOCE DA METFORMINA OU DO ORLISTAT NA PREVENÇÃO DA DISFUNÇÃO DE ADIPÓCITOS EM RATOS WISTAR SUBMETIDOS À DIETA HIPERGLICÍDICA-HIPERLIPÍDICA

Submitted by Angela Maria de Oliveira (amolivei@uepg.br) on 2018-05-14T14:39:42Z No. of bitstreams: 2 license_rdf: 811 bytes, checksum: e39d27027a6cc9cb039ad269a5db8e34 (MD5) Janete Machozeki.pdf: 3460027 bytes, checksum: 87b38a12a4dede2c42dbef87dd9de037 (MD5) === Made available in DSpace on 2018-05...

Full description

Bibliographic Details
Main Author:	Machozeki, Janete
Other Authors:	Costa, Mario Augusto Cray da
Language:	Portuguese
Published:	Universidade Estadual de Ponta Grossa 2018
Subjects:	CNPQ::CIENCIAS DA SAUDE adipócito metformina obesidade orlistat síndrome metabólica Adipocyte metformin obesity metabolic syndrome
Online Access:	http://tede2.uepg.br/jspui/handle/prefix/2498

Similar Items

ORLISTAT : Kan orlistat ha andra hälsoeffekter i kroppen förutom viktminskningseffekten?
by: Mohammadshahi, Faisal
Published: (2017)

Orlistat in polycystic ovarian syndrome reduces weight with improvement in lipid profile and pregnancy rates
by: Pratap Kumar, et al.
Published: (2014-01-01)

A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis
by: Somaye Fatahi, et al.
Published: (2018-09-01)

The effect of orlistat on postprandial hypertriglyceridemia by oral fat loading test: a systematic review
by: Ana Rodríguez-Valle, et al.

Features of Menstrual Disorders in Obese Women and Ways for Their Correction Using Orlistat
by: O.S. Payenok, et al.
Published: (2014-08-01)

A comparative study of the efficacy and safety of the original and generic orlistat in obese patients in the PROFIL register
by: A. V. Zakharova, et al.
Published: (2016-03-01)

The effect of orlistat and weight loss diet on plasma ghrelin and obestatin
by: Baris Pamuk, et al.
Published: (2018-01-01)

LONG-TERM EFFECTS OF ORLISTAT ON EATING BEHAVIOR OF OBESITY PATIENTS
by: E. V. Korneeva
Published: (2015-09-01)

Lipashämmaren orlistats effekt på viktnedgång och typ 2-diabetes
by: Andersson, Sofie
Published: (2009)

Evaluation of efficacy and safety of orlistat in obese patients
by: Suyog S Jain, et al.
Published: (2011-01-01)

Dieta, atividade autonômica e efeitos do orlistat em pacientes com síndrome dos ovários policísticos
by: Graff, Scheila Karen
Published: (2016)

Dieta, atividade autonômica e efeitos do orlistat em pacientes com síndrome dos ovários policísticos
by: Graff, Scheila Karen
Published: (2016)

Dieta, atividade autonômica e efeitos do orlistat em pacientes com síndrome dos ovários policísticos
by: Graff, Scheila Karen
Published: (2016)

ORLISTAT IN COMBINATION THERAPY OF OBESITY AND TYPE 2 DIABETES
by: A. M. Mkrtumyan, et al.
Published: (2017-12-01)

The effect of orlistat on body weight in obese Czech adults
by: Pavlík Vladimír, et al.
Published: (2013-10-01)

Effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss
by: Ana Rodríguez-Valle, et al.

An Unexpected Result of Obesity Treatment: Orlistat-Related Acute Pancreatitis
by: Murat Kose, et al.
Published: (2015-05-01)

Dynamics of lipid profile and circadian pressure rhythms in patients with obesity and arterial hypertension, treated with orlistat and its combination with ACE inhibitors
by: A. G. Avtandilov, et al.
Published: (2005-02-01)

Demographic and clinical characteristics, and adverse reactions of people with overweight and obesity consumers of orlistat, attended by a call center (2009 – 2017)
by: Sandra Rizo Treviño
Published: (2018-10-01)

Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents Revisión sistemática sobre la eficacia clínica de la sibutramina y el orlistat en la pérdida de peso, calidad de vida y sus efectos adversos en obesos adolescentes
by: E. García Díaz, et al.
Published: (2011-06-01)

Anti-Atherogenic Effects of Orlistat on Obesity-Induced Vascular Oxidative Stress Rat Model
by: Zaidatul Akmal Othman, et al.
Published: (2021-02-01)

Influence of Orlistat on Efficacy of Complex Treatment in Patients with Type 2 Diabetes Mellitus and Obesity
by: I.V. Pankiv
Published: (2013-08-01)

Clinical case: Effectiveness of combined therapyOrlistat and Irbesartan at the Metabolic syndrome patient with Arterial hypertension
by: K P Ivanov, et al.
Published: (2009-03-01)

Pharmacodynamic testing and new validated HPLC method to assess the interchangeability between multi-source orlistat capsules
by: Zaid AN, et al.
Published: (2017-11-01)

Development and validation by statistical treatment of stability indicating RP-HPLC method for quantification of Orlistat in Orlistat-loaded solid dispersion
by: Kiran Singh Sharma, et al.
Published: (2021-02-01)

Tinospora crispa Ameliorates Insulin Resistance Induced by High Fat Diet in Wistar Rats
by: Abu, MN, et al.
Published: (2015)

The Application of Quantitative 1H-NMR for the Determination of Orlistat in Tablets
by: Shanshan Sun, et al.
Published: (2017-09-01)

Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial
by: Kwon YJ, et al.
Published: (2021-03-01)

Efeitos do Orlistat na proliferação celular da mucosa colônica e na formação de focos de criptas aberrantes induzidos por Dimetilhidrazina em ratos
by: Luane Taísa da Costa Barros
Published: (2006)

Efeitos do Orlistat na proliferação celular da mucosa colônica e na formação de focos de criptas aberrantes induzidos por Dimetilhidrazina em ratos
by: Barros, Luane Taísa da Costa
Published: (2006)

ELECTRONIC-MICROSCOPIC CHANGES OF THE SPLEEN UNDER THE ACTION OF SODIUM GLUTAMATE AND THEIR CORRECTION BY ORLISTAT
by: Harapko T. V., et al.
Published: (2020-09-01)

Integrated approach in the treatment of metabolic syndrome
Published: (2014-03-01)

Influence of weight loss on the clinical manifestations of osteoarthritis of the knee-joints.
by: Inna Vladimirovna Solov'eva, et al.
Published: (2017-12-01)

EVALUATION OF THE IMPACT OF DRUG THERAPY FOR OBESITY ON THE CLINICAL MANIFESTATIONS OF KNEE OSTEOARTHRITIS IN OVERWEIGHT WOMEN
by: E. A. Strebkova, et al.
Published: (2015-09-01)

Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients
by: Ali Khan R, et al.
Published: (2017-02-01)

Distinctive Gut Microbiota in Patients with Overweight and Obesity with Dyslipidemia and its Responses to Long-term Orlistat and Ezetimibe Intervention: A Randomized Controlled Open-label Trial
by: Jin Jin, et al.
Published: (2021-08-01)

Berberine is as effective as the anti-obesity drug Orlistat in ameliorating betel-nut induced dyslipidemia and oxidative stress in mice
by: Kasturi Bhattacharjee, et al.
Published: (2021-08-01)

Effect of preconceptional orlistat treatment on in-vitro fertilization outcome in overweight/obese women: study protocol for a randomized controlled trial
by: Jing Li, et al.
Published: (2018-07-01)

Effects of Orlistat and herbal mixture extract on brain, testes functions and oxidative stress biomarkers in a rat model of high fat diet
by: Sanaa R. Galaly, et al.
Published: (2014-06-01)

Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs
by: Peter M. Nilsson, et al.
Published: (2010-12-01)